SANOFI-AVENTIS (EPA:SAN) Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine
Directive transparence : information réglementée
21/05/2023 20:17
19/09/2023 08:30
19/09/2023 08:30
11/09/2023 20:02
11/09/2023 20:02
15/08/2023 21:24
15/08/2023 21:24
28/07/2023 13:22
28/07/2023 13:22
28/07/2023 13:17
30/06/2023 09:38